Rivastigmine Tartrate
The tartrate salt formulation of rivastigmine used to improve cognitive symptoms in Alzheimer's disease dementia by maintaining higher levels of the neurotransmitter acetylcholine. It helps with memory, thinking, and daily functioning in people with mild to moderate Alzheimer's.
Moleküler Ağırlık
400,4000 g/mol
TPSA
148,00 Ų
Terapötik Alanlar
Etki Mekanizması
Inhibits acetylcholinesterase, the enzyme that hydrolyzes acetylcholine in the synaptic cleft. This increases acetylcholine availability at cholinergic synapses, enhancing cholinergic neurotransmission.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Inhibits acetylcholinesterase, the enzyme that hydrolyzes acetylcholine in the synaptic cleft. This increases acetylcholine availability at cholinergic synapses, enhancing cholinergic neurotransmission.
2D Yapı
Cite this structure
Embed this structure
SMILES
CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O
InChI
InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m01/s1
Molecular Formula
C18H28N2O8
HBD / HBA
4 / 9
Döndürülebilir Bağlar
8
Ağır Atomlar
28
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
The tartrate salt formulation of rivastigmine used to improve cognitive symptoms in Alzheimer's disease dementia by maintaining higher levels of the neurotransmitter acetylcholine. It helps with memory, thinking, and daily functioning in people with mild to moderate Alzheimer's.
Inhibits acetylcholinesterase, the enzyme that hydrolyzes acetylcholine in the synaptic cleft. This increases acetylcholine availability at cholinergic synapses, enhancing cholinergic neurotransmission.
Yes, Rivastigmine Tartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201092. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 6918078. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="rivastigmine-tartrate"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/rivastigmine-tartrate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/rivastigmine-tartrate/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/rivastigmine-tartrate/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="rivastigmine-tartrate"></drugfyi-drug>